Panniculitis during dasatinib therapy for imatinib-resistant chronic myelogenous leukemia

N Engl J Med. 2006 Jun 15;354(24):2623-4. doi: 10.1056/NEJMc053425.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Benzamides
  • Dasatinib
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myeloid, Chronic-Phase / drug therapy*
  • Middle Aged
  • Panniculitis / chemically induced*
  • Piperazines
  • Protein Kinase Inhibitors / adverse effects
  • Protein-Tyrosine Kinases / antagonists & inhibitors*
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use
  • Thiazoles / adverse effects*
  • Thiazoles / therapeutic use

Substances

  • Antineoplastic Agents
  • Benzamides
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Thiazoles
  • Imatinib Mesylate
  • Protein-Tyrosine Kinases
  • Dasatinib